Ponezumab (PF-04360365), a humanized anti-amyloid IgG2 monoclonal antibody, effectively lowers Abeta levels in the central nervous system and enhances learning and memory performance in mouse models. It holds potential for Alzheimers disease research [1].
CAS Number:
[1178862-65-1]
* VAT and and shipping costs not included. Errors and price changes excepted
